Search Results - "Hynicka, Lauren M"

Vancomycin-Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors by Meaney, Calvin J., Hynicka, Lauren M., Tsoukleris, Mona G.

“…Objective The prevalence of vancomycin‐associated nephrotoxicity (VAN) is reported to vary from 1.0–42.6%, with most data from critically ill patients…”
Get full text

Integrative Medicine Elective for the Wellbeing of Pharmacy Students by Hynicka, Lauren M, Seung, Hyunuk

“…To describe the impact of an integrative medicine elective on the wellbeing of pharmacy students at the University of Maryland School of Pharmacy and examine…”
Get full text

Probable rifaximin-induced neutropenia by Hynicka, Lauren M, Silva, Kathyrn N

“…The development of neutropenia in a patient treated with rifaximin is reported. A 45-year-old Caucasian woman with severe ulcerative colitis arrived at the…”
Get full text

Direct-Acting Antivirals to Prevent Vertical Transmission of Viral Hepatitis C: When Is the Optimal Time to Treat? by Cervino, Leigh, Hynicka, Lauren M.

“…Objective: To describe the most current evidence for the use of direct-acting antivirals (DAAs) to treat hepatitis C along the pregnancy-pediatric continuum in…”
Get full text

A Review of Oral Antiretroviral Therapy for the Treatment of Chronic Hepatitis B by Hynicka, Lauren M, Yunker, Nancy, Patel, Punam H

“…Objective: To describe the current evidence for the use of oral antiretroviral (ARV) agents in the treatment of chronic hepatitis B (CHB). Data Sources: A…”
Get full text

Myxedema Madness: A Case for Short-Term Antipsychotics? by Hynicka, Lauren M.

Get full text

Utility of On-Treatment Viral Loads During Treatment With Direct-Acting Antivirals in Patients Infected With Chronic Viral Hepatitis C by Mortazavi, Shila, Hynicka, Lauren M.

“…Background: Direct-acting antiviral (DAA) agents have revolutionized the treatment of chronic hepatitis C virus (HCV) infection. Current data regarding the…”
Get full text

Noninvasive Fibrosis Assessment in Acute Viral Hepatitis C Infection by Hynicka, Lauren M., Cervino, Leigh, Burgess, Lisa A.

Get full text

A Comprehensive Review of Herbal Supplements Used for Persistent Symptoms Attributed to Lyme Disease by Thompson, Allison, Hynicka, Lauren M, Shere-Wolfe, Kalpana D

“…Lyme disease is the most common, tick-borne disease in the USA. While most patients successfully recover with antibiotics, some patients experience persistent…”
Get full text

Angioedema Secondary to Sofosbuvir/Ledipasvir by Hynicka, Lauren M., Khambaty, Mariam

Get full text

Prophylaxis of Thromboembolic Events in Patients with Nephrotic Syndrome by Pincus, Kathleen J, Hynicka, Lauren M

“…OBJECTIVE To review published literature regarding use of strategies to prevent thrombotic events in patients with nephrotic syndrome (NS). DATA SOURCES The…”
Get full text

Prophylaxis and Treatment of Respiratory Syncytial Virus in Adult Immunocompromised Patients by Hynicka, Lauren M, Ensor, Christopher R

“…Objective: To review the literature regarding current strategies and strategies under active development for the prevention and treatment of respiratory…”
Get full text

Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients by Vega, Ana D, Hynicka, Lauren M, Claeys, Kimberly, Chua, Joel V, Heil, Emily L

“…Data is limited on the use of 8 weeks of therapy with ledipasvir/sofosbuvir (LDV/SOF) for special populations such as HCV-HIV-coinfected patients. The primary…”
Get more information

Hepatitis C Treatment Exposed or Experienced? by Hynicka, Lauren M., Heil, Emily L.

Get full text

Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus by Dunn, Emily E, Vranek, Kathryn, Hynicka, Lauren M, Gripshover, Janet, Potosky, Darryn, Mattingly, 2nd, T Joseph

“…A team-based approach to obtaining prior authorization approval was implemented utilizing a specialty pharmacy, a clinic-based pharmacy technician specialist,…”
Get full text

Anemia Management in Patients with Chronic Viral Hepatitis C by Hynicka, Lauren M, Heil, Emily L

“…OBJECTIVE: To review the literature regarding current strategies for the management of anemia associated with treatment for chronic viral hepatitis C (HCV) in…”
Get full text

Treatment Strategy for a Multidrug-Resistant Klebsiella UTI by Fleming, Erin, Heil, Emily L., Hynicka, Lauren M.

“…Objective: To describe the management strategy for a multidrug-resistant (MDR) Klebsiella urinary tract infection (UTI). Case Summary: A 69-year-old Caucasian…”
Get full text

Future Considerations for the Evaluation of Hepatitis C Virus Treatments in Pan-Genotypic Therapy for Noncirrhotic Treatment-Naive Patients by Calabrese, Martin J, Hynicka, Lauren M, de Bittner, Magaly Rodriguez, Shaya, Fadia T

“…Given the recent approval of the first pan-genotypic chronic hepatitis C virus (HCV) therapy, managed care, health systems, and clinicians will need to…”
Get full text

What does the pharmacological future of treating chronic hepatitis C look like? by Heil, Emily L, Hynicka, Lauren M, Kottilil, Shyam, Tang, Lydia

“…Development of direct acting antivirals has revolutionized the standard of care for the treatment of hepatitis C virus. New interferon-free regimens provide…”
Get more information

Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli? by Wiener, Emily S., Heil, Emily L., Hynicka, Lauren M., Johnson, J. Kristie

“…Objective: To review the data analyzing the role of fluoroquinolones in the treatment of extended-spectrum β-lactamase (ESBL)-producing infections and rates…”
Get full text